Respiratory medications and the risk of cardiac arrhythmias.
about
Managing comorbidities in COPDThe influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settingsValidity of diagnostic coding within the General Practice Research Database: a systematic reviewAtrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study.Impact of Asthma on the Development of Coronary Vasospastic Angina: A Population-Based Cohort Study.Determination and estimation of pharmacokinetic profile of caffeine in form of extract of green tea leaves and its analogy with synthetic form.Risk of atrial fibrillation with high-dose corticosteroids.Glucocorticoids: complications to anticipate and preventCardiac disease in chronic obstructive pulmonary diseaseAtrial Fibrillation and Its Association with Endocrine Disorders.Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stressUpstream effect for atrial fibrillation: still a dilemma?Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.Pharmacological treatment of COPD.Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate.Cardiac Arrhythmias in Patients with Exacerbation of COPD.Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation.
P2860
Q27005858-53A8F70F-AA06-4C22-AFD7-78FB8A178ED7Q33532293-F9094112-A871-4F27-9E0D-2057F99883A4Q33689383-FCC48282-7F00-476A-BD5D-DF0ABCB8CD12Q33741873-4ADC9E60-498D-440A-811B-0BD017226C64Q35012268-28D63273-51E2-4333-ADD5-5E99C16F9F28Q36206806-96BF2541-E0D3-40F6-9171-D84FC70B8D5CQ36346005-B0E5DD75-D284-43A1-A839-EC1B911612BAQ36624987-99F8496A-70DD-4F2A-B72B-30C23B5EB1B9Q37052792-E23BF642-778C-4BFB-8C73-25D3990325F1Q37103712-D84A69DF-563E-41A5-AE56-9B4392662AF9Q37115127-1D89AE82-A531-4558-AB1D-F8080BA6399EQ37210877-793983F7-868D-434E-A98B-A63EDE28E470Q37804417-04F5ABC9-3296-4E5F-B29A-D76AA8B52EE4Q37846370-A97FEB25-F5BB-4D0C-B920-7E9855ADC7F4Q37924598-84279330-C195-41BD-A45A-1301DD17A75CQ46790496-F3A8BCBB-6E32-4502-BF69-CF67190413E3Q47874167-108ED844-BB1A-4C39-B458-28A26B9165C4Q48372198-30BA1E2D-26F1-433A-919F-9C237C22E4F0
P2860
Respiratory medications and the risk of cardiac arrhythmias.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Respiratory medications and the risk of cardiac arrhythmias.
@en
Respiratory medications and the risk of cardiac arrhythmias.
@nl
type
label
Respiratory medications and the risk of cardiac arrhythmias.
@en
Respiratory medications and the risk of cardiac arrhythmias.
@nl
prefLabel
Respiratory medications and the risk of cardiac arrhythmias.
@en
Respiratory medications and the risk of cardiac arrhythmias.
@nl
P2093
P1433
P1476
Respiratory medications and the risk of cardiac arrhythmias.
@en
P2093
Consuelo Huerta
Luis A García Rodríguez
Stephan F Lanes
P304
P356
10.1097/01.EDE.0000158743.90664.A7
P577
2005-05-01T00:00:00Z